Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 15 Stomach Neoplasms 6 Neoplasms 2 Inflammatory Breast Neoplasms 2 Esophageal Neoplasms 2 pCR Rate 1 Triple Negative Breast Neoplasms 1 Testicular Neoplasms 1 Testicular Germ Cell Tumor 1 Rhabdomyosarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Oesophago-gastric Cancer 1 Neoplasms, Germ Cell and Embryonal 1 Nasopharyngeal Carcinoma 1 Epstein-Barr Virus Infections 1 Cardiotoxicity 1 Breast Neoplasms, Male 1

Interventions

Panitumumab 1 Oxaliplatin 1 Epirubicin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Oesophago-gastric Cancer × Epirubicin × Clear all

NCT00824785 2012-12-11

REAL3

Royal Marsden NHS Foundation Trust

Phase 3 Terminated

Gastrointestinal

Oesophago-gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡